SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lance Bredvold who wrote (1437)1/30/2002 9:31:28 AM
From: D.Austin   of 10345
 
P.S. Wanna start a new ELN price target contest?
siliconinvestor.com
.
same story, new day !!!!!!!!!
.

8:46AM Elan shares slide on accounting concerns (ELN) by Ted Griffith
Shares of Irish drugmaker Elan tumbled 20 percent in premarket trading Wednesday after a published report raised questions about the company's accounting practices. A report in the Wall Street Journal questioned the way Elan accounts for partnerships with other companies. The newspaper story quotes an Elan executive defending the company's practices. Shares of Elan (ELN) were down $6.98 to $27.10 in premarket trading.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext